| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/13/2005 | WO2005002518A2 Methods for treating and preventing cardiac arrhythmia |
| 01/13/2005 | WO2005002513A2 C1q complement inhibitors and methods of use thereof |
| 01/13/2005 | WO2005002505A2 Apolipoprotein c-1 induced apoptosis |
| 01/13/2005 | WO2005002502A2 An assay for detecting the presence of processing inhibitory antibodies against the apical membrane antigene-1 of plasmodium falciparum in biological samples |
| 01/13/2005 | WO2005002501A2 Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same |
| 01/13/2005 | WO2005002416A2 Predictors of renal disease |
| 01/13/2005 | WO2004100229A3 Biocompatible sensor electrode assembly and method for the production thereof |
| 01/13/2005 | WO2004097417A8 Structured construct and producing method therefor |
| 01/13/2005 | WO2004086039A3 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 01/13/2005 | WO2004082568A3 Diagnostics and therapeutics for diseases associated with complement component 5a receptor (c5ar) |
| 01/13/2005 | WO2004082567A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 01/13/2005 | WO2004077062A3 Method for selecting a candidate drug compound |
| 01/13/2005 | WO2004075814A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 i (prostaglandin e2 ep3 i) |
| 01/13/2005 | WO2004074321A3 Therapeutic gpcr targets in cancer |
| 01/13/2005 | WO2004072606A3 Polymeric membranes for use in electrochemical sensors |
| 01/13/2005 | WO2004069876A3 Trimeric polypeptide construct to induce an enduring t cell response |
| 01/13/2005 | WO2004069191A3 Identification of t1r and t2r modulators |
| 01/13/2005 | WO2004068116A3 Receptor deorphanization using tagged molecular libraries |
| 01/13/2005 | WO2004066415A3 Thin film semi-permeable membranes for gas sensor and catalytic applications |
| 01/13/2005 | WO2004057345A3 Transport device for transporting test strips in an analysis system |
| 01/13/2005 | WO2004046329A3 Levels of pin1 in normal and cancerous tissue |
| 01/13/2005 | WO2004046164A9 Unique recognition sequences and methods of use thereof in protein analysis |
| 01/13/2005 | WO2004043230B1 A method of screening for disorders of glucose metabolism |
| 01/13/2005 | WO2004041779A3 Amyloid plaque formation by glycosaminoglycans |
| 01/13/2005 | WO2004027381A3 Methods and compositions related to inhibiting nuclear envelope breakdown |
| 01/13/2005 | WO2004024097A8 Compositions and methods for the treatment of immune related diseases |
| 01/13/2005 | WO2004022711A9 Biomap analysis |
| 01/13/2005 | WO2003102592A3 Selective binding and analysis of macromolecules: quantitative analysis of proteins in complex mixtures |
| 01/13/2005 | WO2003102580A8 Method of coupling binding agents to a substrate surface |
| 01/13/2005 | WO2003098199A9 In situ methods for measuring the release of a substance from a dosage form |
| 01/13/2005 | WO2003074073A3 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 01/13/2005 | WO2003012067A3 Expression profile of prostate cancer |
| 01/13/2005 | WO2002092001A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/13/2005 | WO2002014850A9 A process and device for continuous ionic monitoring of aqueous solutions |
| 01/13/2005 | US20050010371 Workflow-based research system with genetic pedigree display and organism tracking |
| 01/13/2005 | US20050010137 Method and device for sampling and analyzing interstitial fluid and whole blood samples |
| 01/13/2005 | US20050010128 Ovulation cycle monitor system, toilet apparatus, and ovulation cycle monitor method |
| 01/13/2005 | US20050010094 Blood sugar level measuring apparatus |
| 01/13/2005 | US20050010042 Expression vector comprising nucleotide sequences comprising pro-polypeptide for use in the diagnosis, prevention and treatment of cell proliferative, inflammatory, cardiovascuar and nervous system disorders |
| 01/13/2005 | US20050010002 Method of determining cationic surfactant |
| 01/13/2005 | US20050009877 Methods of identifying HCV NS5B polymerase inhibitors and their uses |
| 01/13/2005 | US20050009771 Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same |
| 01/13/2005 | US20050009745 TSG101 as inhibitor of HIV production |
| 01/13/2005 | US20050009743 Analyzing changes in protein; genetic engineering |
| 01/13/2005 | US20050009735 Aqueous solution of insulin and surfactant; storage stability |
| 01/13/2005 | US20050009444 Detection of odours using insects |
| 01/13/2005 | US20050009205 Fluorescently labeled G protein coupled receptor ligand comprising motilin for use in monitoring, identifying and screening drugs which modulate or treat cell proliferative disorders |
| 01/13/2005 | US20050009204 Multiplexed binding assays for receptor arrays |
| 01/13/2005 | US20050009203 Kit and/or test strips for screening drugs of abuse; bioassay |
| 01/13/2005 | US20050009202 Methods and compositions for use in the diagnosis and treatment of chronic immune disease |
| 01/13/2005 | US20050009201 Method of spotting probe solution |
| 01/13/2005 | US20050009198 Biosensor apparatus comprising prism which utilizes the angular propagation of light into a substrate to distinguish between light originating from a luminescent source close to the substrate and that from a source further away |
| 01/13/2005 | US20050009196 Method |
| 01/13/2005 | US20050009195 Device for analyzing the alcohol content of respiratory gas |
| 01/13/2005 | US20050009194 Using colorimetric analysis to determine metal concentration in gasolines and distillate fuels |
| 01/13/2005 | US20050009193 Using low density lipoprotein, high density lipoproten and triglyceride concentrations as data tool in designing physical regimen to prevent and/or alleviate cardiovascular disorders |
| 01/13/2005 | US20050009192 Water quality detection system for monitoring concentration of contaminants in drinking water; pollution control |
| 01/13/2005 | US20050009190 Using optical measurement to determine accuracy of test strips used for analyzing blood glucose levels |
| 01/13/2005 | US20050009189 Using transgenic plants comprising enhanced very long chain fatty acid elongases (VLCFAE) as diagnostic tools in detecting modulators of plant growth; herbicides and crop protection |
| 01/13/2005 | US20050009171 Device and method for analyzing ion channels in membranes |
| 01/13/2005 | US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders |
| 01/13/2005 | US20050009141 Epidermal differentiation factor |
| 01/13/2005 | US20050009139 Compositions and methods for generating chimeric heteromultimers |
| 01/13/2005 | US20050009131 Method for determining the biological activity of defibrotide |
| 01/13/2005 | US20050009130 Castable diffusion membrane for enzyme-based sensor application |
| 01/13/2005 | US20050009128 determining homocysteine (Hcy) in samples in which homocysteine reacts with Hcy co-substrate in Hcy conversion reaction catalyzed by Hcy converting enzyme to form Hcy conversion product and Hcy co-substrate conversion product, and Hcy co-substrate conversion product is assessed to determine Hcy in sample |
| 01/13/2005 | US20050009125 Quantitating free cholesterol and/or esterified cholesterol concentration in sample which contains various lipoproteins; diagnosing cardiovascular disease |
| 01/13/2005 | US20050009124 Assays for detection of phosphoinositide kinase and phosphatase activity |
| 01/13/2005 | US20050009123 System for detecting bacteria in blood, blood products, and fluids of tissues |
| 01/13/2005 | US20050009122 Radio frequency identification chip/antennas combined with radio frequency identification interrogators for use in healthcare settings for continuous tracking of patients, physician and health care worker location within medical centers, asset control of hospital capital and monitoring access to pharmacy |
| 01/13/2005 | US20050009121 Hydrolyzing polysaccharides with hydrofluoric acid; high performance chromatography coupled with pulsed amperometric detection; vaccines |
| 01/13/2005 | US20050009120 Using tumor marker, CA 125, gene expression as diagnostic indicator/prognosticator of mammalian mammary gland cell proliferative disorders |
| 01/13/2005 | US20050009119 Using expression of intracellular protein on surface of damaged and/or tumor cells as diagnostic/prognostic indicator of drug resistance; immunotherapy; antitumor agents; genetic vaccines |
| 01/13/2005 | US20050009118 Method for identifying differentially expressed proteins |
| 01/13/2005 | US20050009116 Reagents, methods and kit for detecting feed enzymes |
| 01/13/2005 | US20050009115 Flow cytometer for analysis of general diagnostic factors in cells and body fluids |
| 01/13/2005 | US20050009114 Identification and quantification of organ-specific proteins derived from human allogeneic cells using proteomics |
| 01/13/2005 | US20050009112 Methods for identifying Rheb effectors as lead compounds for drug development for diabetes and diseases associated with abnormal cell growth |
| 01/13/2005 | US20050009111 Identifying modulators which decrease or prevent arrestin transport across membranes; g-protein coupled protein modulators; identifying drug treatments for cardiovascular, inflammatory and respiratory disorders |
| 01/13/2005 | US20050009110 Identifying and rasing monoclonal antibodies specific to endothelial growth factors for use in the treatment and detection infection, autoimmune and cell proliferative disorders |
| 01/13/2005 | US20050009109 Fluorophore compounds and their use in biological systems |
| 01/13/2005 | US20050009108 Using 16s ribosomal RNA as diagnostic tool in detection of campylobacter DNA sequences in biological fluids; diagnosing bacterial infection |
| 01/13/2005 | US20050009105 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2005 | US20050009104 Methods of attaching soluble HLA to solid supports |
| 01/13/2005 | US20050009103 Methods of precise molecular-level determination of ligand-receptor interactions and designing selective drug compounds based on said interactions |
| 01/13/2005 | US20050009102 Bioassay for measuring the concentration of albumin contained in urine |
| 01/13/2005 | US20050009101 Microfluidic devices comprising biochannels |
| 01/13/2005 | US20050009100 Immunoassay method and immunoassay system |
| 01/13/2005 | US20050009099 Determining and monitoring interactions between phage-displayed proteins and test molecules; drug screening; enzyme inhbitors |
| 01/13/2005 | US20050009097 Immunoglobulin specific to epithelial cell adhesion molecule (Ep-CAM) for use in disgnosis and treatment of cell proliferative disorders; immunotherapy |
| 01/13/2005 | US20050009096 Using myelin/oligodendrocyte glycoprotein (MOG) as diagnostic tool in detecting, classifying, evaluating and monitoring allergic encephalomyelitis (EAE) and autoimmune diseases in mammals |
| 01/13/2005 | US20050009095 Using hydrophobicity to determine three-dimensional structure of proteins; molecular modeling of proteins |
| 01/13/2005 | US20050009094 Use of 14-3-3 proteins and a method for determining the same in the fluids or tissues of organisms |
| 01/13/2005 | US20050009093 Focussing of compound libraries using atomic electrotopological values |
| 01/13/2005 | US20050009085 44 Human secreted proteins |
| 01/13/2005 | US20050009082 Beads, preparing method for the same, flow cytometer and program |
| 01/13/2005 | US20050009077 Composition of matter comprising library of first nucleic acid analyte copies |
| 01/13/2005 | US20050009076 Conjugate of hormone (thyroxine) and inosine-5'-monophosphate dehydrogenase inhibitor (such as mycophenolic acid) |
| 01/13/2005 | US20050009074 Implantable monitor of vulnerable plaque and other disease states |
| 01/13/2005 | US20050009073 Polyamide nucleic acid derivatives, and agents, and processes for preparing them |